Day: March 14, 2022

PARIS, March 14, 2022 (GLOBE NEWSWIRE) — Quantum Genomics (Euronext Growth – FR0011648971 – ALQGC), a biopharmaceutical company specializing in the development of a new drug class directly targeting the brain to treat resistant/hard-to-treat hypertension and heart failure, announces that Stéphane Cohen, a pharmacist and ESSEC graduate, is joining the team as Director of Global Operations. He will be responsible for liaising with current and future international partner laboratories, implementing the operational strategy in line with good governance, and preparing the market launch of firibastat. Stéphane Cohen has held operational management and senior leadership positions involving a dozen successful market launches of new treatments in major pharmaceutical companies, particularly at Bayer and Pfizer for eighteen years. “I’m...

TORONTO, March 14, 2022 (GLOBE NEWSWIRE) — Dundee Corporation (TSX: DC.A, DC.PR.B, DC.PR.D) (“Dundee” or the “Company”) announced today that its fourth quarter 2021 financial results will be released after market close on March 28, 2022, followed by a conference call with management for investors and analysts on March 29, 2022 at 10:00 am ET. Analysts and investors are invited to participate using the following dial-in numbers or webcast link: Participant Number (Local): 416-764-8659 Participant number (Toll-free): 1-888-664-6392 Conference ID: 06223587 Audience URL: https://produceredition.webcasts.com/starthere.jsp?ei=1535852&tp_key=ea8ef0244f A replay of the conference call will be available until 11:59 pm (ET) April 12, 2022, and can be accessed using the following dial-in numbers: Encore (Local): 416-764-8677 Encore (Toll-free):...

Gaithersburg, Md., March 14, 2022 (GLOBE NEWSWIRE) — Sodexo, a leader in healthcare food service and facilities management, is the only full services capabilities company awarded a national GPO agreement for Environmental and Facilities Management that includes on-site management services with Premier, Inc. Effective April 1, 2022, the new agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier. “Our experience in transitioning Premier members from self-managed programs to Sodexo shows savings of 10% to 20%. We look forward to offering Premier clients tailored solutions and programs that help hospitals deliver the best possible patient care and meet their operational and compliance requirements. We have the global resources, research-backed programs, and talented...

AB “Ignitis grupė” (hereinafter – the Group) informs that on 14th March 2022 the Management Board of its subsidiary UAB “Ignitis” (hereinafter – the Company) approved the intention to conclude a short-term loan agreement of up to EUR 150 million (hereinafter – the Agreement) with AB Swedbank. Having acquired three unscheduled liquefied natural gas cargoes in 2022 so far, the Company , will use the loan to fund the purchase of additional liquefied natural gas cargoes in order to ensure uninterrupted gas supply for the customers of the Company. The loan also could be used to fund other working capital needs. The Agreement does not include additional measures ensuring the fulfilment of obligations. Other loan terms and conditions are confidential. The Agreement will be signed in the near future, the Group will not inform about its signing...

AB “Ignitis grupė” (hereinafter – the Group) informs that on 14th March 2022 the Management Board of its subsidiary UAB “Ignitis” (hereinafter – the Company) approved the intention to conclude a short-term loan agreement of up to EUR 150 million (hereinafter – the Agreement) with AB Swedbank. Having acquired three unscheduled liquefied natural gas cargoes in 2022 so far, the Company will use the loan to fund the purchase of additional liquefied natural gas cargoes in order to ensure uninterrupted gas supply for the customers of the Company. The loan also could be used to fund other working capital needs. The Agreement does not include additional measures ensuring the fulfilment of obligations. Other loan terms and conditions are confidential. The Agreement will be signed in the near future, the Group will not inform about its signing...

NEXANS Head Officel : 4 allée de l’Arche, 92400 Courbevoie, France  Tel : + 33 (0) 1 78 15 00 00 – www.nexans.com  a French Société Anonyme with a share capital of € 43 755 627 – R.C.S. Nanterre 393 525 852 – Id VAT FR 74 393 525 852                           Disclosure of trading in own shares                    From March 9, 2022 to March 11, 2022                    Issuer : Nexans                      Category : treasury shares                                               Pursuant to applicable law on share buybacks, Nexans declares the following purchases of its own shares from March 9, 2022 to March 11, 2022                             The trades have been executed within the framework of the description of the buyback program published on March 29, 2021, on the Company’s website (www.nexans.com)...

        Company Announcement No 07/2022Peberlyk 46200 AabenraaDenmark Tel +45 74 37 37 37Fax +45 74 37 35 36 Sydbank A/SCVR No DK 12626509, Aabenraasydbank.dk14 March 2022  Dear Sirs Sydbank share buyback programme: transactions in week 10On 2 March 2022 Sydbank announced a share buyback programme of DKK 425m. The share buyback commenced on 7 March 2022 and will be completed by 30 December 2022. The purpose of the share buyback programme is to reduce the share capital of Sydbank and the programme is executed in compliance with the provisions of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016, collectively referred to as the Safe Harbour rules. The following transactions have been made under the share buyback programme:  Number...

TEL AVIV, Israel and NEW YORK, March 14, 2022 (GLOBE NEWSWIRE) — VBL Therapeutics (Nasdaq: VBLT), a late-clinical stage biotechnology company focused on developing first-in-class therapeutics for difficult-to-treat malignant solid tumors and immune or inflammatory indications, today announced that it will release financial results for the year ended December 31, 2021 on Wednesday, March 23 before market open. Professor Dror Harats, M.D., Chief Executive Officer, and Sam Backenroth, Chief Financial Officer, will host a conference call at 8:30am ET to discuss the results and provide a corporate update.Call Details:Wednesday, March 23, 2022 at 8:30am ETConference ID: 13727878US: 1-877-407-9208Israel Local: 1-809-406-247International: 1-201-493-6784Webcast: https://edge.media-server.com/mmc/p/6ntrdxh8 About VBL...

MONTREAL and SARASOTA, Fla., March 14, 2022 (GLOBE NEWSWIRE) — As previously announced and, in light of the Company’s announcement on March 8, 2022, the conference call that had been scheduled for Tuesday, March 15, 2022 at 10 a.m. Eastern time has been canceled. For further information, please contact: Ross Marshall LodeRock Advisors, Inc. Tel : (416) 526-1563